Skip to content

Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display

Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03234504
Enrollment
30
Registered
2017-07-31
Start date
2017-07-24
Completion date
2018-07-31
Last updated
2018-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal Healthy Volunteers

Brief summary

This prospective study investigated the validity and test-retest reliability of stereopsis test using head-mount display (HMD). Contour-based circles (crossed disparity: 1,960 to 195 arc of seconds(arc secs)) were generated as separate images on a high resolution phone display (Galaxy S7; Samsung, Suwon, Korea) using a HMD (Galaxy Gear VR; Samsung, Suwon, Korea). Two images were independently projected to each eye as graded circles with random dot background. While the position of the stimulus changed from among 3 possible locations, the subjects were instructed to select the circle with disparity by pressing the corresponding position on a keypad. The results of the new HMD stereotest were compared to those from standard Randot and TNO stereotests.

Interventions

None listed

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1\. The subjects who want or need to visual acuity test or to test for a prescription for glasses visited the hospital. 2. The Subjects' ages ranged from 19 to 60 years in the study.

Exclusion criteria

1. Ocular alignment was assessed with cover-uncover and alternate prism cover testing at distance and near. Significant exodeviation included exophoria was considered to be ≥6 prism diopters were excluded. 2. Subjects with a history of ocular surgery within 3 months of the study were excluded. 3. Foreigners or subjects who are unable to understand informed consent were excluded. 4. Subjects with a history of eye problems, including infection, inflammation, cataract, vitreous opacity or retinal diseases were excluded. 5. Subjects with corrected visual acuity of 20/32 in bad eye were excluded. 6. Subjects with significant refractive error considered to be ≥2.00 diopters of anisometropia were excluded. 7. A female who is pregnant, may be pregnant, or is lactating was excluded.

Design outcomes

Primary

MeasureTime frameDescription
Correlation between stereopsis with head mount display and stereopsis with Randot or TNO testone visitStereopsis results was expressed as arc sec. The association between log arc sec in stereopsis with HMD display and Randot or TNO test were evaluated. Using Bland Altman plot, the mean differences between two stereopsis results were compared.

Secondary

MeasureTime frameDescription
Test-retest variability of stereopsis using head mount displayone visitThe intraclass coefficient was calculated between initial head mount display stereopsis result and retests.

Countries

South Korea

Contacts

Primary ContactJinu Han, MD
jinuhan@yuhs.ac+82-10-3764-7746

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026